Updating: Merck Affiliates Now Hold Over 10 Per Cent — Almost 31.6 Million Shares — Of Newly Public BeiGene

US Merck updated its SEC Form 4 filing, to indicate that as of February 8, 2016, it had an additional 7.9 million shares, as a result of a note exchange it had entered into with BeiGene. Apparently, the other earlier share totals (from just this past Friday) were prior to the note exchange (those BeiGene final prospectus disclosures put Merck’s 23.7 million shares of holdings at 7.7 per cent of then outstanding shares). Now Merck is certainly an over 10 per cent holder — at 31.58 million shares. I’ll wait for BeiGene’s proxy to specify the new percentage of outstandings, as I don’t have time here at the airport to sort out all the other “Green Shoes” granted in the IPO — and which were exercised, and in what amounts.

In passing, I’ll note that the post IPO trading price of BeiGene has declined a fair amount — but at today’s prices, the 31.58 million shares are worth. . . quite a bit more than Merck put in.

Onward — and keep it spinning in good Karma over the Valentine’s weekend!


There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: